Advertisement

Transcatheter valve interventions in heart failure: new answers to old questions

  • Marijana Tadic
  • Cesare Cuspidi
Article

Abstract

Heart failure (HF) is often associated with different valve diseases, predominantly functional mitral and tricuspid regurgitation. However, the association between HF and aortic stenosis, particularly low-flow low-gradient aortic stenosis, is not infrequent. Severe mitral and tricuspid regurgitations, as well as aortic stenosis, in HF patients worsen prognosis and left ventricular dilatation and induce further reduction in left ventricular ejection fraction. Transcatheter edge-to-edge mitral and tricuspid valve repair and transcatheter aortic valve implantation could be an important therapeutic option with a satisfactory long-term outcome in HF patients with comorbidities and even in patients with severely depressed ejection fraction.

Keywords

Heart failure Transcatheter aortic valve interventions MitraClip Mitral annuloplasty Tricuspid annuloplasty 

Notes

Author contributions

MT and CC were involved in design and writing the article. MT was involved in drafting and CC in revising critically for important intellectual content.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 22(4 Suppl A):6A–13ACrossRefPubMedGoogle Scholar
  2. 2.
    Rahimtoola SH, Cheitlin MD, Hutter AM Jr (1987) Cardiovascular disease in the elderly. Valvular and congenital heart disease. J Am Coll Cardiol 10(2 Suppl A):60A–62ACrossRefPubMedGoogle Scholar
  3. 3.
    Himbert D, Vahanian A (2015) Transcatheter aortic valve replacement for patients with heart failure. Heart Fail Clin 11(2):231–242CrossRefPubMedGoogle Scholar
  4. 4.
    Bursi F, Barbieri A, Grigioni F, Reggianini L, Zanasi V, Leuzzi C, Ricci C, Piovaccari G, Branzi A, Modena MG (2010) Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study. Eur J Heart Fail 12(4):382–388CrossRefPubMedGoogle Scholar
  5. 5.
    Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S, Simioniuc A, Gullace M, Ghio S, Enriquez-Sarano M, Temporelli PL (2011) Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 97(20):1675–1680CrossRefPubMedGoogle Scholar
  6. 6.
    Di Mauro M, Bezante GP, Di Baldassarre A, Clemente D, Cardinali A, Acitelli A, Salerni S, Penco M, Calafiore AM, Gallina S (2013) Italian study group on valvular heart disease Italian Society of Cardiology. Functional tricuspid regurgitation: an underestimated issue. Int J Cardiol 168(2):707–715CrossRefPubMedGoogle Scholar
  7. 7.
    Agricola E, Stella S, Gullace M, Ingallina G, D'Amato R, Slavich M, Oppizzi M, Ancona MB, Margonato A (2012) Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 14(8):902–908CrossRefPubMedGoogle Scholar
  8. 8.
    Philip F, Athappan G, Tuzcu EM, Svensson LG, Kapadia SR (2014) MitraClip for severe symptomatic mitral regurgitation in patients at high surgical risk: a comprehensive systematic review. Catheter Cardiovasc Interv 84(4):581–590CrossRefPubMedGoogle Scholar
  9. 9.
    Nickenig G, Hammerstingl C, Schueler R, Topilsky Y, Grayburn PA, Vahanian A, Messika-Zeitoun D, Urena Alcazar M, Baldus S, Volker R, Huntgeburth M, Alfieri O, Latib A, La Canna G, Agricola E, Colombo A, Kuck KH, Kreidel F, Frerker C, Tanner FC, Ben-Yehuda O, Maisano F (2016) Transcatheter mitral annuloplasty in chronic functional mitral regurgitation: 6-month results with the cardioband percutaneous mitral repair system. JACC Cardiovasc Interv 9(19):2039–2047CrossRefPubMedGoogle Scholar
  10. 10.
    Nickenig G, Kowalski M, Hausleiter J, Braun D, Schofer J, Yzeiraj E, Rudolph V, Friedrichs K, Maisano F, Taramasso M, Fam N, Bianchi G, Bedogni F, Denti P, Alfieri O, Latib A, Colombo A, Hammerstingl C, Schueler R (2017) Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation 135(19):1802–1814CrossRefPubMedGoogle Scholar
  11. 11.
    Schueler R, Hammerstingl C, Werner N, Nickenig G (2017) Interventional direct annuloplasty for functional tricuspid regurgitation. JACC Cardiovasc Interv. 10(4):415–416CrossRefPubMedGoogle Scholar
  12. 12.
    Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008CrossRefPubMedGoogle Scholar
  13. 13.
    Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J.  https://doi.org/10.1093/eurheartj/ehx391
  14. 14.
    Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinationaldatabase of 19030 patients. Eur J Cardiothorac Surg 15(6):816–822CrossRefPubMedGoogle Scholar
  15. 15.
    Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U (2012) EuroSCORE II. Eur J Cardiothorac Surg 41(4):734–744CrossRefPubMedGoogle Scholar
  16. 16.
    Ewe SH, Ajmone Marsan N, Pepi M, Delgado V, Tamborini G, Muratori M, Ng AC, van der Kley F, de Weger A, Schalij MJ, Fusari M, Biglioli P, Bax JJ (2010) Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am Heart J 160(6):1113–1120CrossRefPubMedGoogle Scholar
  17. 17.
    van der Boon RM, Nuis RJ, Van Mieghem NM, Benitez LM, van Geuns RJ, Galema TW, van Domburg RT, Geleijnse ML, Dager A, de Jaegere PP (2012) Clinical outcome following Transcatheter aortic valve implantation in patients with impaired left ventricular systolic function. Catheter Cardiovasc Interv 79(5):702–710CrossRefPubMedGoogle Scholar
  18. 18.
    Gotzmann M, Lindstaedt M, Bojara W, Ewers A, Mügge A (2012) Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis. Catheter Cardiovasc Interv 79(5):693–701CrossRefPubMedGoogle Scholar
  19. 19.
    Pilgrim T, Wenaweser P, Meuli F, Huber C, Stortecky S, Seiler C, Zbinden S, Meier B, Carrel T, Windecker S (2011) Clinical outcome of high-risk patients with severe aortic stenosis and reduced left ventricular ejection fraction undergoing medical treatment or TAVI. PLoS One 6(11):e27556CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Onorati F, D'Errigo P, Grossi C, Barbanti M, Ranucci M, Covello DR, Rosato S, Maraschini A, Santoro G, Tamburino C, Seccareccia F, Santini F, Menicanti L, OBSERVANT Research Group (2014) Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study. J Thorac Cardiovasc Surg 147(2):568–575CrossRefPubMedGoogle Scholar
  21. 21.
    Herrmann HC, Pibarot P, Hueter I, Gertz ZM, Stewart WJ, Kapadia S, Tuzcu EM, Babaliaros V, Thourani V, Szeto WY, Bavaria JE, Kodali S, Hahn RT, Williams M, Miller DC, Douglas PS, Leon MB (2013) Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: placement of aortic transcatheter valves (PARTNER) trial analysis. Circulation 127(23):2316–2326CrossRefPubMedGoogle Scholar
  22. 22.
    Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, Kodali S, Leon MB, Svensson L, Pibarot P, Douglas PS, Fearon WF, Kirtane AJ, Maniar HS, Passeri JJ, PARTNER Investigators (2013) Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the placement of aortic transcatheter valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv 6(6):604–614CrossRefPubMedGoogle Scholar
  23. 23.
    Baron SJ, Arnold SV, Herrmann HC, Holmes DR Jr, Szeto WY, Allen KB, Chhatriwalla AK, Vemulapali S, O'Brien S, Dai D, Cohen DJ (2016) Impact of ejection fraction and aortic valve gradient on outcomes of transcatheter aortic valve replacement. J Am Coll Cardiol 67(20):2349–2358CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Carreras ET, Kaneko T, Ramirez-Del Val F, Pelletier MP, Sobieszczyk PS, Bhatt DL, Shah PB (2017) Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement. Catheter Cardiovasc IntervGoogle Scholar
  25. 25.
    Conrotto F, D'Ascenzo F, D'Amico M, Moretti C, Pavani M, Scacciatella P, Omedè P, Montefusco A, Biondi-Zoccai G, Gaita F, Maisano F, Nietlispach F (2017) Outcomes of patients with low-pressure aortic gradient undergoing transcatheter aortic valve implantation: a Meta-analysis. Catheter Cardiovasc Interv 89(6):1100–1106CrossRefPubMedGoogle Scholar
  26. 26.
    Le Ven F, Freeman M, Webb J, Clavel MA, Wheeler M, Dumont É, Thompson C, De Larochellière R, Moss R, Doyle D, Ribeiro HB, Urena M, Nombela-Franco L, Rodés-Cabau J, Pibarot P (2013) Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement. J Am Coll Cardiol 62(9):782–788CrossRefPubMedGoogle Scholar
  27. 27.
    Sato K, Kumar A, Jones BM, Mick SL, Krishnaswamy A, Grimm RA, Desai MY, Griffin BP, Rodriguez LL, Kapadia SR, Obuchowski NA, Popović ZB (2017) Reversibility of cardiac function predicts outcome after transcatheter aortic valve replacement in patients with severe aortic stenosis. J Am Heart Assoc 6(7)Google Scholar
  28. 28.
    Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011CrossRefPubMedGoogle Scholar
  29. 29.
    Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, Lüscher TF, Moat N, Price S, Dall'Ara G, Winter R, Corti R, Grasso C, Snow TM, Jeger R, Blankenberg S, Settergren M, Tiroch K, Balzer J, Petronio AS, Büttner HJ, Ettori F, Sievert H, Fiorino MG, Claeys M, Ussia GP, Baumgartner H, Scandura S, Alamgir F, Keshavarzi F, Colombo A, Maisano F, Ebelt H, Aruta P, Lubos E, Plicht B, Schueler R, Pighi M, di Mario C, Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology (2014) Transcatheter valve treatment sentinel registry investigators of the EURObservational Research Programme of the European Society of Cardiology. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 pilot European sentinel registry. J Am Coll Cardiol 64(9):875–884CrossRefPubMedGoogle Scholar
  30. 30.
    Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D, EVEREST Investigators (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (endovascular valve edge-to-edge repair study) cohort. J Am Coll Cardiol 54(8):686–694CrossRefPubMedGoogle Scholar
  31. 31.
    Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T (2014) Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol 64(2):172–181CrossRefPubMedGoogle Scholar
  32. 32.
    Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA, Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L, EVEREST II Investigators (2015) Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 66(25):2844–2854CrossRefPubMedGoogle Scholar
  33. 33.
    Attizzani GF, Ohno Y, Capodanno D, Cannata S, Dipasqua F, Immé S et al (2015) Extended use of percutaneous edge-to-egde mitral valve repair beyond EVEREST (endovascularvalve edge-to-edge repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (getting reduction of mitral insufficiency by percutaneous clip implantation) registry. JACC Cardiovasc Interv 8(1 Pt A):74–82CrossRefPubMedGoogle Scholar
  34. 34.
    Pleger ST, Schulz-Schönhagen M, Geis N, Mereles D, Chorianopoulos E, Antaredja M, Lewening M, Katus HA, Bekeredjian R (2013) One year clinical efficacy and reverse remodeling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip implantation. Eur J Heart Fail 15(8):919–927CrossRefPubMedGoogle Scholar
  35. 35.
    Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W (2013) Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, non-randomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 62(12):1052–1061CrossRefPubMedGoogle Scholar
  36. 36.
    Schäfer U, Maisano F, Butter C, Franzen O, Baldus S, Hausleiter J, Ussia GP, Sievert H, Geist V, Widder JD, Moccetti T, Schillinger W (2016) Impact of pre-procedural left ventricular ejection fraction on 1-year outcomes after MitraClip implantation (from the ACCESS-EU phase I, a prospective, multicenter, non-randomized postapproval study of the MitraClip therapy in Europe). Am J Cardiol 118(6):873–880CrossRefPubMedGoogle Scholar
  37. 37.
    Velazquez EJ, Samad Z, Al-Khalidi HR, Sangli C, Grayburn PA, Massaro JM, Stevens SR, Feldman TE, Krucoff MW (2015) The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J 170(5):1050–1059CrossRefPubMedGoogle Scholar
  38. 38.
    Schueler R, Öztürk C, Sinning JM, Werner N, Welz A, Hammerstingl C, Nickenig G (2017) Impact of baseline tricuspid regurgitation on long-term clinical outcomes and survival after interventional edge-to-edge repair for mitral regurgitation. Clin Res Cardiol 106(5):350–358CrossRefPubMedGoogle Scholar
  39. 39.
    Barth S, Hautmann MB, Kerber S, Gietzen F, Reents W, Zacher M, Halbfass P, Griese DP, Schieffer B, Hamm K (2017) Left ventricular ejection fraction of <20%: too bad for Mitraclip©? Catheter Cardiovasc IntervGoogle Scholar
  40. 40.
    Lubos E, Schlüter M, Vettorazzi E, Goldmann B, Lubs D, Schirmer J, Treede H, Reichenspurner H, Blankenberg S, Baldus S, Rudolph V (2014) MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome. JACC Cardiovasc Interv. 7(4):394–402CrossRefPubMedGoogle Scholar
  41. 41.
    Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, Levy WC, Mauri L, Feldman T, Kwong RY, Kaye DM, Duffy SJ, Tübler T, Degen H, Brandt MC, Van Bibber R, Goldberg S, Reuter DG, Hoppe UC (2009) Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLOM mitral annuloplasty device European Union study. Circulation 120(4):326–333CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Siminiak T, Wu JC, Haude M, Hoppe UC, Sadowski J, Lipiecki J, Fajadet J, Shah AM, Feldman T, Kaye DM, Goldberg SL, Levy WC, Solomon SD, Reuter DG (2012) Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN trial. Eur J Heart Fail 14(8):931–938CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Lipiecki J, Siminiak T, Sievert H, Müller-Ehmsen J, Degen H, Wu JC, Schandrin C, Kalmucki P, Hofmann I, Reuter D, Goldberg SL, Haude M (2016) Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial. Open Heart 3(2):e000411CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Goldberg SL, Meredith I, Marwick T, Haluska BA, Lipiecki J, Siminiak T, Mehta N, Kaye DM, Sievert H, REDUCE FMR Investigators (2017) A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure—trial design of the REDUCEFMR study. Am Heart J 188:167–174CrossRefPubMedGoogle Scholar
  45. 45.
    Sack S, Kahlert P, Bilodeau L, Pièrard LA, Lancellotti P, Legrand V, Bartunek J, Vanderheyden M, Hoffmann R, Schauerte P, Shiota T, Marks DS, Erbel R, Ellis SG (2009) Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circ Cardiovasc Interv 2(4):277–284CrossRefPubMedGoogle Scholar
  46. 46.
    Machaalany J, Bilodeau L, Hoffmann R, Sack S, Sievert H, Kautzner J, Hehrlein C, Serruys P, Sénéchal M, Douglas P, Bertrand OF (2013) Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenousmitral annuloplasty system: results of the multicenter international percutaneous transvenous mitral annuloplasty system to reduce mitral valve regurgitation in patients with heart failure trial. Am Heart J 165(5):761–769CrossRefPubMedGoogle Scholar
  47. 47.
    Harnek J, Webb JG, Kuck KH, Tschope C, Vahanian A, Buller CE, James SK, Tiefenbacher CP, Stone GW (2011) Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (clinical evaluation of the Edwards Lifesciences percutaneous mitral annuloplasty system for the treatment of mitral regurgitation). JACC Cardiovasc Interv 4(1):115–122CrossRefPubMedGoogle Scholar
  48. 48.
    Rogers JH, Thomas M, Morice MC, Narbute I, Zabunova M, Hovasse T, Poupineau M, Rudzitis A, Kamzola G, Zvaigzne L, Greene S, Erglis A (2015) Treatment of heart failure with associated functional mitral regurgitation using the ARTO system: initial results of the first-in-human MAVERIC trial (mitral valve repair clinical trial). JACC Cardiovasc Interv 8(8):1095–1104CrossRefPubMedGoogle Scholar
  49. 49.
    Maisano F, Vanermen H, Seeburger J, Mack M, Falk V, Denti P, Taramasso M, Alfieri O (2012) Direct access transcatheter mitral annuloplasty with sutureless and adjustable device: preclinical experience. Eur J Cardiothorac Surg 42(3):524–529CrossRefPubMedGoogle Scholar
  50. 50.
    Maisano F, Taramasso M, Nickenig G, Hammerstingl C, Vahanian A, Messika-Zeitoun D, Baldus S, Huntgeburth M, Alfieri O, Colombo A, La Canna G, Agricola E, Zuber M, Tanner FC, Topilsky Y, Kreidel F, Kuck KH (2016) Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J 37(10):817–825CrossRefPubMedGoogle Scholar
  51. 51.
    Barbanti M, Piazza N, Mangiafico S, Buithieu J, Bleiziffer S, Ronsivalle G, Scandura S, Giuffrida A, Popolo Rubbio A, Mazzamuto M, Sgroi C, Lange R, Tamburino C (2017) Transcatheter mitral valve implantation using the HighLife system. JACC Cardiovasc Interv 10(16):1662–1670CrossRefPubMedGoogle Scholar
  52. 52.
    Rodés-Cabau J, Taramasso M, O’Gara PT (2016) Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet 388:2431–2442CrossRefPubMedGoogle Scholar
  53. 53.
    Hammerstingl C, Schueler R, Malasa M, Werner N, Nickenig G (2016) Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J 37(10):849–853CrossRefPubMedGoogle Scholar
  54. 54.
    Calen C, Taramasso M, Guidotti A, Kuwata S, Nietlispach F, Zuber M, Maisano F (2017) Successful TriCinch-in-TriCinch transcatheter tricuspid valve repair. JACC Cardiovasc Interv 10(8):e75–e77CrossRefPubMedGoogle Scholar
  55. 55.
    Braun D, Nabauer M, Orban M, Orban M, Gross L, Englmaier A, Rösler D, Mehilli J, Bauer A, Hagl C, Massberg S, Hausleiter J (2017) Transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique. EuroIntervention 12(15):e1837–e1844CrossRefPubMedGoogle Scholar
  56. 56.
    Perlman G, Praz F, Puri R, Ofek H, Ye J, Philippon F, Carrel T, Pibarot P, Attinger A, Htun NM, Dvir D, Moss R, Campelo-Parada F, Bédard E, Reineke D, Moschovitis A, Lauck S, Blanke P, Leipsic J, Windecker S, Rodés-Cabau J, Webb J (2017) Transcatheter tricuspid valve repair with a new transcatheter coaptation system for the treatment of severe tricuspid regurgitation: 1-year clinical and echocardiographic results. JACC Cardiovasc Interv 10(19):1994–2003CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Internal Medicine and Cardiology, Department of Cardiology, Campus Virchow Klinikum (CVK)Charité – Universitätsmedizin BerlinBerlinGermany
  2. 2.Clinical Research UnitUniversity of Milan-Bicocca and Istituto Auxologico ItalianoMedaItaly

Personalised recommendations